Universal Beteiligungs und Servicegesellschaft mbH Sells 14,457 Shares of Encompass Health Corporation $EHC

Universal Beteiligungs und Servicegesellschaft mbH trimmed its stake in Encompass Health Corporation (NYSE:EHC) by 13.5% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 92,965 shares of the company’s stock after selling 14,457 shares during the quarter. Universal Beteiligungs und Servicegesellschaft mbH owned approximately 0.09% of Encompass Health worth $11,808,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors also recently modified their holdings of the company. Royal Bank of Canada lifted its stake in Encompass Health by 21.5% in the first quarter. Royal Bank of Canada now owns 88,470 shares of the company’s stock valued at $8,960,000 after purchasing an additional 15,677 shares during the last quarter. Millennium Management LLC raised its stake in shares of Encompass Health by 38.4% in the first quarter. Millennium Management LLC now owns 92,197 shares of the company’s stock valued at $9,338,000 after buying an additional 25,574 shares during the period. Caxton Associates LLP purchased a new position in shares of Encompass Health during the 1st quarter valued at $259,000. Sowell Financial Services LLC bought a new position in shares of Encompass Health during the 2nd quarter worth $215,000. Finally, Park Avenue Securities LLC increased its holdings in Encompass Health by 28.5% in the 2nd quarter. Park Avenue Securities LLC now owns 9,153 shares of the company’s stock worth $1,122,000 after acquiring an additional 2,030 shares during the last quarter. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Encompass Health Trading Down 1.0%

NYSE EHC opened at $98.36 on Friday. The company has a quick ratio of 1.14, a current ratio of 1.14 and a debt-to-equity ratio of 0.76. The stock’s 50-day simple moving average is $107.79 and its two-hundred day simple moving average is $115.60. Encompass Health Corporation has a twelve month low of $92.53 and a twelve month high of $127.99. The company has a market capitalization of $9.90 billion, a price-to-earnings ratio of 18.59, a PEG ratio of 1.58 and a beta of 0.74.

Encompass Health (NYSE:EHC) last announced its quarterly earnings data on Wednesday, October 29th. The company reported $1.23 earnings per share for the quarter, topping analysts’ consensus estimates of $1.19 by $0.04. Encompass Health had a net margin of 9.33% and a return on equity of 17.84%. The firm had revenue of $1.48 billion during the quarter, compared to analyst estimates of $1.48 billion. During the same period in the previous year, the business posted $1.03 EPS. The business’s quarterly revenue was up 9.4% on a year-over-year basis. Research analysts forecast that Encompass Health Corporation will post 4.8 EPS for the current fiscal year.

Wall Street Analyst Weigh In

EHC has been the topic of several recent research reports. Weiss Ratings reaffirmed a “buy (b+)” rating on shares of Encompass Health in a report on Wednesday, October 8th. Raymond James Financial raised shares of Encompass Health to a “strong-buy” rating in a report on Friday, October 31st. Wall Street Zen upgraded shares of Encompass Health from a “hold” rating to a “buy” rating in a research note on Sunday, January 18th. Zacks Research downgraded Encompass Health from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, November 19th. Finally, Barclays raised their price target on Encompass Health from $141.00 to $150.00 and gave the stock an “overweight” rating in a report on Thursday, October 30th. Two equities research analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating and one has assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, Encompass Health has an average rating of “Buy” and a consensus target price of $142.86.

Encompass Health Company Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.